Biocardia Stock Investor Sentiment
| BCDA Stock | USD 2.28 0.09 3.80% |
About 58% of all Biocardia's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Biocardia suggests that some traders are interested. The current market sentiment, together with Biocardia's historical and current headlines, can help investors time the market. In addition, many technical investors use Biocardia stock news signals to limit their universe of possible portfolio assets.
Biocardia |
Biocardia Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Biocardia can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Biocardia that are available to investors today. That information is available publicly through Biocardia media outlets and privately through word of mouth or via Biocardia internal channels. However, regardless of the origin, that massive amount of Biocardia data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biocardia news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biocardia relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biocardia's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biocardia alpha.
Biocardia Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Allen Jim L. of 50000 shares of Biocardia at 3.0 subject to Rule 16b-3 | 09/03/2024 |
2 | Acquisition by Peter Altman of 1000 shares of Biocardia at 2.4877 subject to Rule 16b-3 | 09/13/2024 |
3 | Acquisition by Allen Jim L. of 829 shares of Biocardia at 2.65 subject to Rule 16b-3 | 10/11/2024 |
4 | Short Interest in BioCardia, Inc. Decreases By 12.6 | 10/15/2024 |
5 | BioCardia Completes Phase III Randomized Double-Blind Controlled Trialof Autologous Cell Therapy for Ischemic Heart Failure | 10/28/2024 |
6 | Urogen Pharma Reports Q3 Loss, Tops Revenue Estimates | 11/06/2024 |
7 | Acquisition by Allen Jim L. of 12434 shares of Biocardia at 4.43 subject to Rule 16b-3 | 11/11/2024 |
8 | BioCardia Reports Third Quarter 2024 Business Highlights and Financial Results | 11/13/2024 |
9 | BioCardia, Inc. Q3 2024 Earnings Call Transcript | 11/15/2024 |
10 | Biocardia CEO Peter Altman acquires 2,524 in common stock | 11/19/2024 |
Complementary Tools for Biocardia Stock analysis
When running Biocardia's price analysis, check to measure Biocardia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocardia is operating at the current time. Most of Biocardia's value examination focuses on studying past and present price action to predict the probability of Biocardia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocardia's price. Additionally, you may evaluate how the addition of Biocardia to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |